Like what you're reading? Forward to a friend.
Sometimes you can judge a company by its name, though...

Bad Name, Broken Deals: Five of ten planned deals for Schwazze, a (weirdly named) Colorado-based would-be vertically integrated operator, have fallen through, canceled by either Schwazze or the target. Only the acquisition of MesaPur, which required a relatively smaller amount of cash, has transacted, while the remainder remain in limbo, as tight capital markets have collided with a declining stock price at Schwazze to create an unfavorable climate for deals. Schwazze needed at least $96 million in cash to complete the deals, and still needs $70+ million to close those that are still active (including the 14 dispensary Starbuds acquisition).
Why It Matters: Deals… seem to be dead. It’s a little hard to sort out what the real situation is at The Company Formerly Known As Medicine Man Technologies. It’s possible this announce-and-kill pattern reflects strategic prioritization - at least some of its deals (Los Suenos and Dabble) were killed off by the company itself, ostensibly because of diligence issues, and Starbuds, as the by-far largest acquisition, looms large. But the question of whether Schwazze really has the wherewithal to do any of the deals remains. 

The Name Tells It All...: dot.LA has an absolutely riveting multi-article series going on the collapse of the (ironically named) Los Angeles-based Genius Fund, which blew $164 million in Russian oligarch money in less than two years. The company aspired to build a vertically-integrated cannabis business, starting or investing in a large hemp farm in northern California, cannabis kiosks and a line of CBD products like sparkling water and candles, a retail presence, production facility, and more. Nearly all were failures, as inexperienced executives, inordinate spend, little industry familiarity, and shady dealings combined to sink the enterprises.
Why It Matters: Man, could you imagine a better candidate for a movie covering the 2016 - 2018 cannabis bubble? The story is one that continuously gets both more insane and more believable, encapsulating how the worst the industry has seen - an unbelievable amount of money burnt for essentially no value in a blaze of inexperience, greed, incompetency, and potential fraud (with a now-dead Russian billionaire’s dollars, to keep things extra spicy). More than anything, I’m still wondering -- how did this company spend $165 million… and I’ve barely heard of them?

Quick Hits

Research Rips

👍 Cannabis Use May Have Anti-inflammatory Effects
👍 Cannabis Has Potential To Regulate Neurogenic Inflammation
👍 Use of Cannabinoids Could Be Beneficial In Traumatic Brain Injuries and MS
👍 Prescription Stimulant Use Is Higher In Non-Medical Marijuana States 
👎 Cannabis May Have Therapeutic Benefits, But Few Seem To Be Cardiovascular
👎 Cannabis Use During Pregnancy Linked To Autism Risk

Recapping some of our best and most recent long reads

Was this email forwarded to you? Sign up here.
Forward to a friend!
Have thoughts? Know a killer brand? Looking for help?

Email us, or hit us up at the below:
Was this email forwarded to you? Sign up here.
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.


This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Seed To Sale Tales · 1930 Ridge Ave Apt C104 · Evanston, IL 60201-6213 · USA

Email Marketing Powered by Mailchimp